PROGRAMS - Overview

Today more than 60 million American adults are suffering from mental illness. Despite the significant unmet medical need for drugs with improved efficacy and reduced side effects, the current pipeline of new agents is very limited. Furthermore, in the last 40 years, few new targets or breakthrough therapeutic approaches for treating psychiatric disorders have been identified.

We believe that understanding neuronal function and network activity is critical for elucidating new mechanisms in CNS disease.